Home / Services / Engineered microbial and Mammalian Hosts for High-Performance Production / Insects Chassis Engineering / Sf9 Cells Genome Editing & Metabolic Engineering Solutions / Insect Cells Genome Editing & Metabolic Engineering Solutions / Custom Insect Cell Strain Development and Screening Services
Insect Cell Strain Development & Screening

Custom Insect Cell Strain Development and Screening Services

From clonal isolation to performance validation — accelerate your insect cell-based bioproduction and research.

  • Clonal isolation and expansion for stable cell lines
  • Phenotypic and genotypic screening for target traits
  • Cryopreserved master cell banks with QC documentation

Tailored Strain Development for Insect Cell Systems

We provide end-to-end development and screening of insect cell strains (including Sf9, Sf21, and Drosophila cell lines) for recombinant protein production, baculovirus expression, and functional genomic studies. Each project is designed around your target trait and throughput requirements.

  • Multiple insect cell hosts available (e.g., Sf9, Sf21, Schneider 2)
  • High-throughput screening using microplate-based growth and expression.
  • Stability assessment over defined passage number
Drosophila & Sf9
High-Throughput Screening
Stability Validation
OUR APPROACH

Systematic Insect Cell Strain Development

Our integrated workflow combines clonal engineering, high-throughput screening, and rigorous quality control to deliver characterized insect cell strains with documented performance and stability.

Genotype-Driven Engineering & Clonal Isolation

Projects begin with the selection or engineering of your target insect cell line. We employ transfection, random mutagenesis, or directed evolution to introduce desired traits, followed by single-cell cloning to generate a panel of clonal candidates for screening.

  • Multiple engineering approaches (transfection, mutagenesis, selection)
  • Single-cell cloning via limiting dilution or FACS
  • Initial genotypic characterization (PCR, sequencing)

High-Throughput Phenotypic Screening

Clone panels are screened for growth kinetics, productivity, and other relevant performance metrics using automated microplate assays. Hits are identified based on predefined thresholds and validated in repeat experiments.

  • Growth rate and viability profiling
  • Target protein expression quantification (ELISA, Western blot, activity assay)
  • Hit confirmation and prioritization for further expansion

Custom Assay Development

Screening assays are tailored to your specific trait — whether it's recombinant protein yield, metabolic output, or resistance to culture stress. We design readouts that directly correlate with your downstream application.

Passage Stability & Cryopreservation

Lead clones are cultured over multiple passages to assess genetic and phenotypic stability. Stable strains are cryopreserved as research cell banks with documented viability and identity.

Project documentation & Traceability

Every step from cell sourcing to final bank is recorded, providing a transparent audit trail. Deliverables include a screening report, cell bank certificate, and recommended culture conditions.

WHAT YOU RECEIVE

Integrated Deliverables for Insect Cell Strain Projects

Our standard package includes characterized cell lines, performance data, and quality documentation. Additional analytics can be scoped per project.

Standard Deliverables

  • Cryopreserved documented research-grade cell bank (not a GMP master cell bank unless scoped) (≥10 vials per selected clone)
  • Screening report summarizing growth, productivity, and stability data
  • PCR or sequencing confirmation of engineered genotype (when applicable)
  • Recommended culture conditions and passaging protocol

Optional Add-Ons

  • Full transcriptomic or proteomic profiling of lead clones
  • Serum-free medium adaptation and scale-up assessment
  • Extended stability study over 20+ passages
  • Custom QC packages (mycoplasma, adventitious agents, isoenzyme analysis)
SERVICE SCOPE

Insect Cell Strain Development — Parameter & Typical Project Scope

Each project is defined after consultation. The table below outlines common parameters; exact scope, clone numbers, and timeline are established in the project SOW.

Parameter Typical project scope
Target Host Cell Line Sf9, Sf21, Schneider 2, or other insect cell lines; can be customer-supplied or sourced
Engineering Approach Transfection (plasmid/viral), random mutagenesis (chemical/UV), or direct selection; type determined by project goals
Screening Readouts Growth rate, viability, recombinant protein titer (ELISA/activity)
Number of Candidate Clones Screened Scoped per project after consultation
Stability Passaging Assessment over 10–20 passages; extended stability study available as add-on
Quality Control Viability post-thaw, mycoplasma testing, genotype confirmation (PCR/sequencing)
WORKFLOW

A Five-Step Development & Screening Process

Our standardized process ensures consistent, documented delivery of characterized insect cell strains. Project-specific modifications are discussed during the initiation phase.

Cell Line Acquisition & Characterization

We obtain or receive your target insect cell line, review provenance, assess morphology and growth, and establish a baseline stock for subsequent engineering steps; molecular identity checks are defined separately in the scope. Initial quality checks include viability and mycoplasma testing.

Engineering & Clonal Isolation

Desired genetic modifications or selective pressures are applied (e.g., transfection, random mutagenesis). Single-cell cloning is performed via limiting dilution or FACS to generate a panel of clonal candidates for screening.

High-Throughput Phenotypic Screening

Clone panels are arrayed in microplates and assessed for growth kinetics, target expression, and other relevant traits using automated liquid handling and detection platforms. Multiple rounds of screening refine the hit list.

Clone Expansion & Validation

Lead clones are expanded into shake-flask or small bioreactor cultures for in-depth validation. Performance metrics are confirmed, and genotypic stability is assessed over several passages.

Cryopreservation & Documentation

Validated clones are cryopreserved as research cell banks with documented viability and identity. A final report summarizing all screening data, stability results, and recommended culture conditions is delivered.

APPLICATIONS

Where Insect Cell Strain Development Adds Value

Our service supports a range of research and biomanufacturing needs where stable, high-performing insect cell lines are essential.

High-Yield Protein Expression

Develop insect cell strains optimized for maximal yield of recombinant proteins, including complex therapeutic glycoproteins and virus-like particles.

  • Stable clones with consistent expression across passages
  • Adaptable to serum-free media for cGMP readiness
  • Detailed productivity data at multiple scales

Baculovirus-Mediated Production

Create and screen permissive insect cell strains that support high-titer baculovirus stocks and robust recombinant protein output.

  • Clones selected for virus infection efficiency and yield
  • Screening for reduced aggregation and proteolysis
  • Stability data under infection conditions

Cell-Based Assay Platforms

Generate reporter or engineered insect cell lines for compound screening, pathway studies, or target validation in Drosophila or other insect models.

  • Stable reporter cell lines (e.g., luciferase, fluorescent proteins)
  • High-throughput compatible clonal panels
  • Validated assay performance (Z'-factor, signal-to-noise)
FREQUENTLY ASKED QUESTIONS

Common Inquiries About Insect Cell Strain Development

Answers to typical questions regarding scope, timelines, and deliverables for insect cell strain development projects.

  • We routinely work with Sf9, Sf21, Hi5, and Drosophila Schneider 2 (S2) cells. Other insect lines (e.g., BTI-Tnao38, Ea4) can be accommodated on a case-by-case basis. The optimal host depends on your target trait and downstream application; we can advise during the project design phase.

  • Project timelines vary based on engineering approach, number of clones, and validation depth. As a general guide, from cell acquisition to cryopreservation of validated clones, projects typically range from 8 to 14 weeks. Exact timelines are confirmed in the project SOW.

  • We assess growth rate, viability, and target expression (if applicable) over a minimum of 10 passages. A stability report includes passage-wise trends, statistical analysis, and any observed drift. Extended stability studies over 20+ passages are available as an optional add-on.

  • Yes. Our screening infrastructure supports a wide array of readouts, including metabolic activity, reporter gene expression, cell size distribution, and resistance to stressors (e.g., temperature or pH).

Scientific Literature

References

  1. Redhai S, Pilgrim C, Gaspar P, et al. An intestinal zinc sensor regulates food intake and developmental growth. Nature. 2020;580(7802):263-268. View on PubMed
  2. Al KF, Daisley BA, Chanyi RM, et al. Oxalate-Degrading Bacillus subtilis Mitigates Urolithiasis in a Drosophila melanogaster Model. mSphere. 2020;5(5). View on PubMed
  3. Eleftherianos I, Heryanto C, Bassal T, et al. Haemocyte-mediated immunity in insects: Cells, processes and associated components in the fight against pathogens and parasites. Immunology. 2021;164(3):401-432. View on PubMed

Ready to Start Your Project?

Get a customized quote for your Custom Insect Cell Strain Development and Screening Services project. Our experts will respond within 24 hours.

No obligation
24h response
Expert consultation
Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.